TY  - GEN
AU  - Liu,Joyce F
AU  - Matulonis,Ursula A
TI  - What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
SN  - 1534-6269
PY  - 2016///1213
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - BRCA1 Protein
KW  - genetics
KW  - BRCA2 Protein
KW  - Disease-Free Survival
KW  - Female
KW  - Humans
KW  - Mutation
KW  - Ovarian Neoplasms
KW  - drug therapy
KW  - Phthalazines
KW  - administration & dosage
KW  - Piperazines
KW  - Poly(ADP-ribose) Polymerase Inhibitors
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1007/s11912-016-0515-z
ER  -